Literature DB >> 30508552

Screening initiation with FIT or colonoscopy: Post-hoc analysis of a pragmatic, randomized trial.

Caitlin C Murphy1, Chul Ahn2, Sandi L Pruitt2, Amy E Hughes2, Ethan A Halm2, Samir Gupta2, Noel O Santini2, Katharine McCallister2, Joanne M Sanders2, Amit G Singal2, Celette Sugg Skinner2.   

Abstract

Screening with FIT or colonoscopy can reduce CRC mortality. In our pragmatic, randomized trial of screening outreach over three years, patients annually received mailed FITs or colonoscopy invitations. We examined screening initiation after each mailing and crossover from the invited to other modality. Eligible patients (50-64 years, ≥1 primary-care visit before randomization, and no history of CRC) received mailed FIT kits (n = 2400) or colonoscopy invitations (n = 2400) from March 2013 through July 2016. Among those invited for colonoscopy, we used multinomial logistic regression to identify factors associated with screening initiation with colonoscopy vs. FIT vs. no screening after the first mailing. Most patients were female (61.8%) and Hispanic (48.9%) or non-Hispanic black (24.0%). Among those invited for FIT, 56.6% (n = 1359) initiated with FIT, whereas 3.3% (n = 78) crossed over to colonoscopy; 151 (15.7%) and 61 (7.7%) initiated with FIT after second and third mailings. Among those invited for colonoscopy, 25.5% (n = 613) initiated with colonoscopy whereas 18.8% (n = 452) crossed over to FIT; 112 (8.4%) and 48 (4.2%) initiated with colonoscopy after second and third mailings. Three or more primary-care visits prior to randomization were associated with initiating with colonoscopy (OR 1.49, 95% CI 1.17-1.91) and crossing over to FIT (OR 1.63, 95% CI 1.19-2.23). Although nearly half of patients initiated screening after the first mailing, few non-responders in either outreach group initiated after a second or third mailing. More patients invited to colonoscopy crossed over to FIT than those assigned to FIT crossed over to colonoscopy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal neoplasms; Health promotion; Mass screening; Pragmatic clinical trial; Safety-net providers

Mesh:

Year:  2018        PMID: 30508552      PMCID: PMC6362977          DOI: 10.1016/j.ypmed.2018.11.020

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  15 in total

1.  A mixed-effects multinomial logistic regression model.

Authors:  Donald Hedeker
Journal:  Stat Med       Date:  2003-05-15       Impact factor: 2.373

2.  Prevalence of colorectal cancer screening in a large medical organization.

Authors:  Sarah T Hawley; Sally W Vernon; Bernard Levin; Beryl Vallejo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-02       Impact factor: 4.254

3.  Tailored interventions for screening mammography among a sample of initially non-adherent women: when is a booster dose important?

Authors:  Celette Sugg Skinner; Sarah C Kobrin; Patrick O Monahan; Joanne Daggy; Usha Menon; Helen Smith Todora; Victoria L Champion
Journal:  Patient Educ Couns       Date:  2006-07-26

4.  Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.

Authors:  Amit G Singal; Samir Gupta; Celette Sugg Skinner; Chul Ahn; Noel O Santini; Deepak Agrawal; Christian A Mayorga; Caitlin Murphy; Jasmin A Tiro; Katharine McCallister; Joanne M Sanders; Wendy Pechero Bishop; Adam C Loewen; Ethan A Halm
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

5.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Authors:  Amy B Knudsen; Ann G Zauber; Carolyn M Rutter; Steffie K Naber; V Paul Doria-Rose; Chester Pabiniak; Colden Johanson; Sara E Fischer; Iris Lansdorp-Vogelaar; Karen M Kuntz
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

6.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Diane M Harper; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

7.  Correlates of Patient Intent and Preference on Colorectal Cancer Screening.

Authors:  Masahito Jimbo; Ananda Sen; Melissa A Plegue; Sarah T Hawley; Karen Kelly-Blake; Mary Rapai; Minling Zhang; Yuhong Zhang; Mack T Ruffin
Journal:  Am J Prev Med       Date:  2017-02-03       Impact factor: 5.043

8.  Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Authors:  John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward
Journal:  Arch Intern Med       Date:  2012-04-09

9.  Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.

Authors:  Sarah T Hawley; Robert J Volk; Partha Krishnamurthy; Maria Jibaja-Weiss; Sally W Vernon; Suzanne Kneuper
Journal:  Med Care       Date:  2008-09       Impact factor: 2.983

10.  Colorectal cancer screening mode preferences among US veterans.

Authors:  Adam A Powell; Diana J Burgess; Sally W Vernon; Joan M Griffin; Joseph P Grill; Siamak Noorbaloochi; Melissa R Partin
Journal:  Prev Med       Date:  2009-09-08       Impact factor: 4.018

View more
  5 in total

1.  A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.

Authors:  Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

2.  Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis.

Authors:  Amit G Singal; Yixing Chen; Shrihari Sridhar; Vikas Mittal; Hannah Fullington; Muzeeb Shaik; Akbar K Waljee; Jasmin Tiro
Journal:  Clin Gastroenterol Hepatol       Date:  2021-03-02       Impact factor: 13.576

3.  A stepped randomized trial to promote colorectal cancer screening in a nationwide sample of U.S. Veterans.

Authors:  Sally W Vernon; Deborah J Del Junco; Sharon P Coan; Caitlin C Murphy; Scott T Walters; Robert H Friedman; Lori A Bastian; Deborah A Fisher; David R Lairson; Ronald E Myers
Journal:  Contemp Clin Trials       Date:  2021-04-03       Impact factor: 2.261

4.  Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.

Authors:  Samir Gupta; Gloria D Coronado; Keith Argenbright; Alison T Brenner; Sheila F Castañeda; Jason A Dominitz; Beverly Green; Rachel B Issaka; Theodore R Levin; Daniel S Reuland; Lisa C Richardson; Douglas J Robertson; Amit G Singal; Michael Pignone
Journal:  CA Cancer J Clin       Date:  2020-06-25       Impact factor: 286.130

5.  Clinician Variation in Ordering and Completion of Low-Dose Computed Tomography for Lung Cancer Screening in a Safety-Net Medical System.

Authors:  David E Gerber; Heidi A Hamann; Olivia Dorsey; Chul Ahn; Jessica L Phillips; Noel O Santini; Travis Browning; Cristhiaan D Ochoa; Joyce Adesina; Vijaya Subbu Natchimuthu; Eric Steen; Harris Majeed; Amrit Gonugunta; Simon J Craddock Lee
Journal:  Clin Lung Cancer       Date:  2020-12-11       Impact factor: 4.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.